Praxis Precision Medicines Inc. (PRAX) PT Raised to $143 at Oppenheimer
Tweet Send to a Friend
Oppenheimer analyst Francois Brisebois raised the price target on Praxis Precision Medicines Inc. (NASDAQ: PRAX) to $143.00 (from $134.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
